195 related articles for article (PubMed ID: 24901824)
1. A distinct pattern of disease-associated single nucleotide polymorphisms in IBD risk genes in a family with Crohn's disease.
Barthel C; Spalinger MR; Brunner J; Lang S; Fried M; Rogler G; Scharl M
Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):803-6. PubMed ID: 24901824
[TBL] [Abstract][Full Text] [Related]
2. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
3. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
[TBL] [Abstract][Full Text] [Related]
4. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.
Abad C; González-Escribano MF; Diaz-Gallo LM; Lucena-Soto JM; Márquez JL; Leo E; Crivell C; Gómez-García M; Martín J; Núñez-Roldán A; García-Lozano JR
Genes Immun; 2011 Dec; 12(8):635-42. PubMed ID: 21716313
[TBL] [Abstract][Full Text] [Related]
5. Differences in genetic background between active smokers, passive smokers, and non-smokers with Crohn's disease.
van der Heide F; Nolte IM; Kleibeuker JH; Wijmenga C; Dijkstra G; Weersma RK
Am J Gastroenterol; 2010 May; 105(5):1165-72. PubMed ID: 19953089
[TBL] [Abstract][Full Text] [Related]
6. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
7. Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn's Disease: On the Way to Personalized Medicine?
Hoffmann P; Lamerz D; Hill P; Kirchner M; Gauss A
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34198814
[TBL] [Abstract][Full Text] [Related]
8. NOD2 sequencing in Iranian children with Crohn's disease.
Motamed F; Najafi M; Taghvaei M; Moazzami K; Farahmand F; Khodadad A; Fallahi GH; Parvaneh N; Khatami GR; Rezaei N
Z Gastroenterol; 2011 Jul; 49(12):1526-8. PubMed ID: 22139875
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants associated with early age of diagnosis of IBD.
Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
[TBL] [Abstract][Full Text] [Related]
10. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort.
Spalinger MR; Voegelin M; Biedermann L; Zeitz J; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
Digestion; 2016; 93(3):182-92. PubMed ID: 26928573
[TBL] [Abstract][Full Text] [Related]
11. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
[TBL] [Abstract][Full Text] [Related]
12. PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population.
Morgan AR; Han DY; Huebner C; Lam WJ; Fraser AG; Ferguson LR
Tissue Antigens; 2010 Aug; 76(2):119-25. PubMed ID: 20403149
[TBL] [Abstract][Full Text] [Related]
13. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
[TBL] [Abstract][Full Text] [Related]
14. Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort.
Weersma RK; Stokkers PC; Cleynen I; Wolfkamp SC; Henckaerts L; Schreiber S; Dijkstra G; Franke A; Nolte IM; Rutgeerts P; Wijmenga C; Vermeire S
Am J Gastroenterol; 2009 Mar; 104(3):630-8. PubMed ID: 19174780
[TBL] [Abstract][Full Text] [Related]
15. IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes.
Lauriola M; Ugolini G; Rivetti S; Nanì S; Rosati G; Zanotti S; Montroni I; Manaresi A; Zattoni D; Belluzzi A; Castellani L; D'Uva G; Mattei G; Taffurelli M; Strippoli P; Solmi R
Int J Mol Med; 2011 Mar; 27(3):469-77. PubMed ID: 21206965
[TBL] [Abstract][Full Text] [Related]
16. PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background.
Glas J; Wagner J; Seiderer J; Olszak T; Wetzke M; Beigel F; Tillack C; Stallhofer J; Friedrich M; Steib C; Göke B; Ochsenkühn T; Karbalai N; Diegelmann J; Czamara D; Brand S
PLoS One; 2012; 7(3):e33682. PubMed ID: 22457781
[TBL] [Abstract][Full Text] [Related]
17. Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects.
Turpin W; Bedrani L; Espin-Garcia O; Xu W; Silverberg MS; Smith MI; Garay JAR; Lee SH; Guttman DS; Griffiths A; Moayyedi P; Panaccione R; Huynh H; Steinhart HA; Aumais G; Dieleman LA; Turner D; ; Paterson AD; Croitoru K
BMC Med Genet; 2020 Oct; 21(1):204. PubMed ID: 33059653
[TBL] [Abstract][Full Text] [Related]
18. Genetic risk profiling and gene signature modeling to predict risk of complications after IPAA.
Sehgal R; Berg A; Polinski JI; Hegarty JP; Lin Z; McKenna KJ; Stewart DB; Poritz LS; Koltun WA
Dis Colon Rectum; 2012 Mar; 55(3):239-48. PubMed ID: 22469789
[TBL] [Abstract][Full Text] [Related]
19. The NOD2 p.Leu1007fsX1008 mutation (rs2066847) is a stronger predictor of the clinical course of Crohn's disease than the FOXO3A intron variant rs12212067.
Schnitzler F; Friedrich M; Wolf C; Angelberger M; Diegelmann J; Olszak T; Beigel F; Tillack C; Stallhofer J; Göke B; Glas J; Lohse P; Brand S
PLoS One; 2014; 9(11):e108503. PubMed ID: 25365249
[TBL] [Abstract][Full Text] [Related]
20. Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn's disease in a New Zealand population.
Ferguson LR; Han DY; Fraser AG; Huebner C; Lam WJ; Morgan AR; Duan H; Karunasinghe N
Mutat Res; 2010 Aug; 690(1-2):108-15. PubMed ID: 20109474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
